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There seems to be growing controversy among interest groups worldwide about whether genetically modified
(GM) foods need to be labelled. There are also growing concerns, particularly among civil society groups, about the
potential danger of GM foods, for which labels are being demanded. Particularly in Africa, the issue of labelling GM
foods requires attention due to the rapid growth of agricultural biotechnology initiatives. Using Kenya as a case
study, and based on interviews with key agricultural stakeholders and a review of the literature, we present five
points to consider in discussions on how the need for mandatory GM labelling should be assessed. This framework
encompasses, and is underpinned by, important considerations about ethics, consumer autonomy, costs,
stigmatization, feasibility and food security as they pertain to agricultural biotechnology.
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Labelling of genetically modified (GM) foods has become
an issue requiring attention in Africa due to the rapid
growth of public-private partnerships operating agricul-
tural biotechnology initiatives. Since partners must adhere
to a given country’s laws on biosafety and labelling, it is
imperative that countries are also clear about the stipula-
tions outlined in any GM labelling law as there is much
concern among the private sector in Africa – be it war-
ranted or not – that labels on GM products will raise fear
and suspicion among the public and thereby stymie ac-
ceptance of agricultural biotechnology in the continent.
In our latest social audita engagement with one such
initiative, the Water Efficient Maize for Africa (WEMA)
project, we asked key agricultural stakeholdersb about any
regulatory challenges facing the WEMA project. Among
their responses, some stakeholders – particularly seed
companies – voiced concern about the implications of the
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reproduction in any medium, provided the orboth the progress and future role of these initiatives. The
WEMA project is a public-private partnership that in-
volves funding partners such as the Bill & Melinda Gates
and Howard G Buffett Foundations, as well as partner in-
stitutions such as the African Agricultural Technology
Foundation, International Maize and Wheat Improvement
Center, Monsanto, and national agricultural research sys-
tems in five African countries (Kenya, Mozambique, South
Africa, Tanzania and Uganda). The goal of the partnership
is to develop drought-tolerant and insect-protected maize
and make these varieties available royalty-free to small-
holder farmers in sub-Saharan Africa through seed com-
panies.c
For the past decade, the introduction of GM ingredi-
ents in food products has been at the centre of highly
controversial and polarizing debates in many countries.
Because there is a wide gap between scientific judgment
and public opinion on GM food, governments are con-
fronted with the dilemma of how to regulate the market-
ing of GM food products. One option for regulating GM
foods is to permit them but ensure segregation from
their conventional counterparts, which implies creating
two separate production tracks and introducing a label-
ling scheme to allow consumers to choose between GM
and non-GM food products [1]. However, the choice ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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form across countries. During the last decade, over 40
countries globally have required GM products to be la-
belled [2]. Some countries, such as the United States
and Canada, have opted for a voluntary labelling scheme,
while other countries such as European Union (EU)
member states, Japan and Australia have opted for a
mandatory labelling scheme, arguing that consumers
have the right to know [3].
The issue of labelling GM foods has begun to gain sa-
lience in East Africa, specifically in Kenya, where GM
crops are in the process of gaining approval for commer-
cial production. We assess the cogency and practicality
of the arguments for and against GM food labelling by
using Kenya, which introduced mandatory GM labelling
in May 2012, as a case study.
The debate on labelling of GM food products encom-
passes complex issues that are entangled in conflicting
interests and beliefs about the production, consumption
and implications of GM foods, as well as ethical con-
cerns such as those over consumers’ right to know what
is in their food. We posit in this paper that the argu-
ments underpinning the imperative to label GM foods
need to be assessed within a framework in which ethics,
consumer autonomy, costs, stigmatization, feasibility and
food security are all considered. Based on the concerns
about GM labelling raised by some stakeholders in our
2012 Social Audit, we seek to explore the logic behind
these arguments to allow for an understanding of the
implications of mandatory GM labelling in the context
of Africa.
GM labelling regulations in Africa
Current status
To date, Burkina Faso, South Africa, Egypt and Sudan are
the only African countries that have approved biotech
crops for commercial production [4,5]. Nigeria, Kenya and
Uganda currently have GM crops under confined field
trials [4]. Of the aforementioned countries, only South
Africa and Kenya have regulations for GM labelling in
place.
In South Africa, the regulations governing the labelling of
foods containing genetically modified organisms (GMOs) is
outlined in Section 24 of the Consumer Protection Act,
2008 (No 68 of 2008) [6], which was signed into law on 24
April 2009 and came into effect on 31 March 2011 [7].
The Act sets out the minimum requirements to ensure
adequate consumer protection and provides an overarch-
ing framework for all other laws that provide for con-
sumer protection. Under the Act, Regulation 293 makes a
provision for a ‘may contain genetically modified ingredi-
ents’ clause, which relieves companies from labelling foods
if it is ‘scientifically impractical or not feasible to test foods’
for the presence of GMOs or GM ingredients [8]. On9 October 2012, the Department of Trade and Industry
published draft amendments to the Consumer Protection
Act stipulating that all imported or locally produced food
containing 5% or more GM components or ingredients
must now be labelled as ‘contains genetically modified in-
gredients or components’ [9].
In 2009, Kenya passed the Biosafety Act, No 2 of 2009,
which allows for commercialization of GM crops [10].
The Government of Kenya (GOK) first required the GM
content of foods, feed or ingredients to be identified on
product labels in 2010 when the Kenya Bureau of Stan-
dards published regulation KS 2225:2010 [11]. Most re-
cently, the GOK, through Kenya Gazette Supplement No
48 of 2012,d introduced additional requirements on GM-
containing foods – which are referred to as the ‘Biosafety
(Labeling) Regulations, 2012’ [12]. In particular, the new
regulations stipulate the following: 1) a reduction of the
adventitious presence of unapproved events from 5 to 1%,
2) use of ‘GMO-Free’ labelling can only be used where
the GM adventitious presence is below a 1% threshold,
3) labels should refer to the GM content in the same font
size used for the other ingredients and trademarks, and
4) references to the CODEX Standard CAC/GL 76 2011
[11]. Violation of the newly gazetted regulations car-
ries a fine of up to 20 million Kenyan shillings (approxi-
mately US$235,300) and/or imprisonment of up to ten
years [12].
Reaction to the newly introduced GM labelling
regulations in Kenya
Reactions to the new labelling regulations in Kenya are
diverse, and have sparked intense public debate among
pro- and anti-GM actors alike. We herein provide a gen-
eral picture of what the public debate looks like and the
various stakeholders who have voiced their views based
on media reporting on the new labelling regulations in
Kenya. Some in Kenya call the new regulations a ‘victory’
and ‘consumer rights milestone’ [13], as those in favour
of the regulations usually assert that Kenyans have a
‘right to know’ what goes in their food and should be
‘protect[ed]’ [14].
On the other hand, millers are calling for an urgent
review of the new regulation, which they claim is too
prohibitive and likely to cause food shortages in the
country. They argue that they will incur additional costs
to meet the labelling requirements, which will have to
be passed on to consumers, and that the new regula-
tion will curtail free and fair trade in GM foods [15].
Kenyan scientists working in the field of biotechnol-
ogy research have criticized the new regulation for lack-
ing a scientific basis [16]. Experts and politicians have
warned that such labelling may increase food prices,
thereby hindering efforts to address food security needs in
the country [15].
Oh and Ezezika Agriculture & Food Security 2014, 3:8 Page 3 of 8
http://www.agricultureandfoodsecurity.com/content/3/1/8Balancing the interests at stake: five points to
consider
Based on the reactions above, it is evident that the views
of certain stakeholders are in conflict. Biased though these
views may be, there will inevitably exist conflicting inter-
ests. For one, some consumers may continue to demand
labels, and food companies – particularly millers – will
continue to insist that labels will increase their costs. We
outline the current debate and the conflicting – and often
diametrically opposed – opinions and views on GM food
labelling in the form of a number of points. We then ex-
plain how these competing interests can be woven into
the discussion on GM food labelling regulations.
Right to know and consumer autonomy
Many have defined the rationale for GM labelling strictly
as a ‘right to know’ issue – that consumers have a right to
know what is in the foods they purchase. Embedded in
the right-to-know argument is the notion of autonomy:
GM labels allow consumers to exercise their freedom to
choose (and avoid) which foods to purchase – be it GM,
organic or conventional [17]. Many studies have unpacked
GM labelling in terms of consumer autonomy [18-20].
Similarly, proponents of GM labels believe that labelling
highlights the value of transparency by honouring all
concerns about GM foods along a range of perspec-
tives – from health or allergen to moral and religious
[21]. Respecting consumers’ autonomy of choice does not
necessarily mean, however, that someone (e.g., producers,
retailers or public authorities) is morally obliged to ensure
that both GM and non-GM food products are available in
the market [18,22].
On the other hand, this insistence on a right to know
whether foods have been produced with GM ingredients
seems to stem from the fear and uncertainty among the
public about the unknown health and environmental ef-
fects of GM foods. According to proponents of mandatory
GM labelling, labelling of new products – such as GM
foods – that currently have no known risk of adverse ef-
fects to human health is a moral imperative from the
viewpoint of public health ethics [21]. For example, anti-
GM activists usually corroborate their claims with re-
search that has shown that GM food is harmful to human
health, such as the published study by French researchers
showing evidence of cancer tumours in rats fed a diet of
Monsanto’s GM maize NK603 [23,24]. This study was im-
mediately criticized by scientists, who mentioned a num-
ber of methodological problems – its small sample size,
the chosen breed of rats (which are predisposed to devel-
oping tumours) and that the tumour rates did not increase
in proportion to the dose of GMOs fed to the rats [25,26].
These findings also contradict those of other long-term
studies in which GM foods were fed to a wide range of lab
animals. Snell et al. [27] published a review of 24 similarlong-term studies and concluded that those studies do not
provide evidence of health hazards. In particular, when
many in the scientific community and agencies such as
the European Food Safety Authority have concluded that
the study is of ‘insufficient scientific quality to be consid-
ered as valid for risk assessment’ [28], such studies should
not serve as a valid guide to the safety of GM foods.
While consumer autonomy is the long-familiar ration-
ale for GM labelling, some also argue that consumer
choice and autonomy do not justify mandatory labelling
of GM foods. Michael Reiss, for example, suggests that
the principle of choice should be held both at the level
of retailers and at the level of individual consumers: con-
sumers who insist on knowing whether their food contains
GMOs will seek out retailers that label and consumers
who do not have a deep interest in knowing such informa-
tion will not seek GM labels [29]. Similarly, Hansen argues
that it is not obvious that autonomy by itself justifies
mandatory labelling: ‘Consumers have all the information
they need if they simply assume that every product that is
not specifically labelled “GM-Free” or “organic” may con-
tain GM ingredients’ [22].
Further, while GM labels have the potential to contrib-
ute positively to consumer education and awareness – as
has been the case with nutrition labels – some argue that
GM labels are only useful for the consumer who already
reads the ingredients list. Gruere et al. state, ‘Information
concerning GMO content in a parenthesis in the ingredi-
ents list is not very likely to catch the eye of the average
consumer’ [3]. In South Africa, for example, in which a
mandatory labelling law recently superseded the voluntary
labelling scheme, and despite significant levels of GM food
crop production in the country, the majority of South
Africans are not aware of the existence of GM foods, nor
are they aware that they are consuming GM foods [30].
Given studies such as this one, we suggest that, while GM
labels can potentially increase consumer awareness about
GMOs, improving consumers’ knowledge and awareness
of agricultural biotechnology can facilitate consumers’
interpretation of GM labels, thereby maximizing the
benefits – that is, choice and information – consumers
obtain from labels.
Chris Macdonald deconstructs the right-to-know argu-
ment and points to the flip side by asking: are agri-food
companies ethically obligated to provide labels? Mac-
donald, focusing on the Canadian context, argues that
individual companies do not have an ethical obligation
toward consumers to label their GM foods: ‘although
unilateral action in this regard might be admirable, an
agri-food company has no ethical obligation to label its
GM foods, given the current social, legal, scientific, and
economic context’ [31]. In other words, the lack of any
scientific research showing that GM foods are harmful
to human health makes moot the ethics argument: since
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ies are not acting unethically if they fail to provide labels
on their GM products.
Costs
A mandatory GM labelling law makes imperative a dis-
cussion about the costs of implementation. Labelling
GM foods entails much more than the mere production
of a sticker or label indicating the presence of GM ingre-
dients; the different procedures that must be fulfilled at
various stages of the entire food production chain poten-
tially impose costs on farmers, traders, manufacturers, the
government and, ultimately, consumers. These include the
technicalities of grain production, handling, processing
and storage. One study found that the bulk of costs in-
curred would be from measures of segregation and iden-
tity preservation to prevent or limit mixing within the
non-GM supply chain [32]. In a study examining the eco-
nomic effects of GMO regulations, Bullock and Desquil-
bet found that tolerance levels are a ‘key element of costs
of non-GMO segregation, and zero-tolerance levels may
be impossible to obtain without major organizational and
economic costs’ [33]. Another study, however, shows that
there is an insignificant difference in the number of prod-
ucts requiring GM labelling when comparing a threshold
level of GM material of 1% and 5% [8]. The different re-
sults from these studies may be attributed to the differ-
ence in the countries examined.
Many, especially agri-food companies and food manu-
facturers, point out the significant costs involved in
mandatorily labelling GM products. For example, a study
conducted to capture the perspectives of major stake-
holders in the Kenyan food industry concluded that, while
most respondents deem important the traceability of GM
products and ingredients, many do not support labelling
of GM products because of the associated extra costs and
the possibility of negative reactions from consumers [34].
While there have been studies done [5,35,36], though all
ex ante, showing that mandatory labelling will create
additional costs that will eventually be passed on to the
consumer, actual increases in food prices due to mandatory
GM labelling have not yet been reported. One study
based on the current EU regulations in 2001 found that
mandatory GM labelling results in an added per capita an-
nual cost of approximately US$0.23 [37].
There is a need for more case-by-case assessments about
the economic costs implied by mandatory GM labelling
to obviate unsubstantiated claims verbalized by the food
industry. Nevertheless, consumers should not accept, at
face value, statements made by leaders in the food indus-
try conveying that consumers will bear the costs of GM
labels – which are often not impartial. The ‘cost’ argument
seems to be overemphasized by the GM food industry to
avoid the real fear of stigmatization – which we discuss inthe next section. African governments can therefore bene-
fit from credible assessments that allow them to deter-
mine the economic viability of regulating the mandate
within their respective countries before introducing a la-
belling law, as well as to determine which stakeholders
may actually be affected. More studies assessing the po-
tential economic costs of mandatory labelling in Africa,
however, are needed, since most of the cost experiments
done pertaining to mandatory GM labelling are based on
the experiences of countries outside of Africa.
Stigmatization
Opponents of mandatory GM labelling – which usually
includes the agri-food industry – deem such labels as
stigmatizing a product that does not deserve to be treated
so. Moreover, our latest Social Audit of the WEMA project
has revealed that the issue of labelling GM foods – particu-
larly, the stigmatization of GM products and the potential
impact on the cost of WEMA seeds – is a concern to
stakeholders, particularly seed companies [38]. Regardless
of whether or not these views are valid or authoritative,
we included a discussion about stigmatization because
it seems to underlie the biotech food industry’s over-
all opposition to GM labels.
Stigma is defined as ‘a mark placed on a person, place,
technology, or product associated with a particular attri-
bute that identifies it as different and deviant, flawed or
undesirable’, such that the perceived consequences of
using a product or service ‘exceed the direct physical
harm to human beings and ecosystems to include more
indirect effects on the economy, social institutions and
well-being’ [39]. Stigma is associated with negative attri-
butions about the source of the mark, and there is in-
deed evidence that genetic modification is cognitively
linked to negative objects and attributes – such as tam-
pering and artificiality – and to concepts such as danger
[40]. Baker and Burnham [41] suggest that mandatory la-
belling may raise concerns among consumers about GM
foods and therefore stigmatize them, and raise the biotech
food industry’s fears about consumer rejection. This argu-
ment seems to suggest that ignorance of food ingredients
is synonymous with acceptance of GM food products;
however, it is not an unwarranted point given the wide-
spread negative perceptions of GMOs.
As it stands, GM food labels have no relation to the safety
of GMOs but are used to provide consumer choice. But
given the current sociopolitical context in many African
countries, labels on GM products at this time could give
the impression of a possible danger, and, in turn, imply
falsely that something is wrong with them. For example,
some bring up the ‘guilt by association’ argument – that
GM labels, particularly in the current climate, give the
false impression that the food is less safe than conven-
tional foods; conversely, a ‘GMO-free’ label may imply
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taining GMOs [42]. In such cases, the disclosing of GM
ingredients through labelling may be more misleading
than informative.
It has also been said that the stigmatizing of GM prod-
ucts that ensues from such impressions can significantly
affect the efficiency of the market by reducing demand
for GM products or inflating demand for their counter-
parts (conventional and organic) [39]. And there seems to
be no significant difference in the reactions induced by a
positive (e.g., ‘contains GMOs’) or negative (e.g., ‘non-GMO’)
label – both have the potential to give rise to negative per-
ceptions about GM foods [39]. One experimental study
showed that consumers perceive GM labels as a negative
signal, and that labels may therefore lower the expected
market share of GM foods [43]. This is a problem because
it implies that the labels on GM foods are not adequately
and accurately informing consumers. Mandatorily label-
ling all food – to convey whether it is GM, organic or
conventional (e.g., treated with pesticides) – may seem to
be a logical solution to avoid stigmatizing only GM foods.
Yet, in a context characterized by sensational reporting on
GM foods and increasing anti-GM movements around
the world, and in which it is increasingly recognized that
‘organic’ labels are used more for marketing purposes than
to inform consumers, the foods labelled as ‘GM’ will be
seen as least desirable; in this way, labels on GM foods
can be considered stigmatizing.
While significant panels such as the World Health
Organization, the International Council for Science and
the Food and Agricultural Organization – to name a few –
have reached the conclusion that GM foods do not pose
risks to human health [44-46], media sensationalism and
anti-GM activists continue to raise consumer fears by dis-
regarding or downplaying the current scientific evidence
on GM foods. Against this sort of backdrop, ‘GM’ labels
can perpetuate and exacerbate fear of GM foods and en-
gender more confusion. At the same time, when the bio-
tech food industry amplifies the cost aspect of GM labels,
they may be placing GMOs in a more undesirable light by
adding to consumers’ negative perceptions: not only may
GM foods be unsafe for human consumption, but they
may now be more expensive if they are labelled – the cost
of which consumers will have to bear.
Feasibility
What is perhaps most germane in the African context is
assessing the feasibility of labelling GM produce sold in
informal markets such as open-air and roadside markets.
These informal markets are crucial for household food
security: they provide a direct source of income for the
low-income vendors that run them; are an important
outlet for small producers due to the less stringent re-
quirements for product quality and packaging; and arean especially important outlet for poor consumers in
both urban and rural areas because of familiarity, greater
accessibility and ability to buy in smaller quantities [47].
It is unclear how the new regulations for GM labelling
in Kenya will be enforced for the unpackaged produce
sold in informal markets – though, there is mention
that for products that are not pre-packaged, ‘the words
“genetically modified organisms” or “genetically modified
(name of organism)” shall appear on, or in connection
with, the display of the product’ [12]. However, Kenya’s
new labelling regulations do not apply to foods sold
by restaurants and food vendors. In Kenya’s Biosafety
(Labelling) Regulations, 2012, section 5d states that these
regulations shall not apply to ‘food intended for consump-
tion prepared and sold from food premises and vendors’
[12]. These regulations also state that the objectives thereof
are a) to ensure that consumers are made aware that food,
feed or a product is genetically modified so that they can
make informed choices; and b) to facilitate the traceability
of genetically modified organism products to assist in the
implementation of appropriate risk management measures
where necessary’ [12]. It is unclear whether the exemption
will apply to food vendors at open-air markets and road-
side kiosks. If it does not, the implication is slightly con-
cerning: the majority of the rural and urban poor in Africa
rely on informal retail markets to obtain staple products
and fresh produce, which means many people would not
have access to GM labels and are thus left uninformed
about whether their food is genetically modified.
Impact on food security and innovation
Studies on whether GM labels implemented in Kenya
will increase the cost of food have yet to be done. Should
GM labels increase costs, however, access to food will be
negatively affected. Like the EU member states, many
African governments have chosen to follow the precau-
tionary approach toward regulating GM foods and crops,
for reasons ranging from cultural ties and agricultural
trade relations to the amount of bilateral foreign assist-
ance Africa receives from Europe [48]. But the circum-
stances of Africa are very different than those of Europe.
In Africa, the percentage of the population that might
benefit directly from GM crops is much higher than in
Europe, because 60% or more of all Africans are still
farmers who depend directly on agriculture for income
and subsistence, while farmers in Europe are highly pro-
ductive even without using GM crops [48].
Innovations such as crop biotechnology offer one po-
tential solution to combating hunger and malnutrition
in developing regions. Without innovation in agriculture,
the Green Revolution, for example, would never have
achieved the remarkable success it did in Asia in contrib-
uting to a substantial increase in food production and re-
ducing poverty. The private sector, through public-private
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and development of biotech crops that will improve agri-
cultural productivity in Africa. For example, the WEMA
project has been firmly established in Kenya, South Africa
and Uganda – among five participating countries – and is
close to achieving its goal of providing small-scale farmers
with drought-tolerant maize varieties. Maize is a staple
food for over 300 million people in sub-Saharan Africa,
many of whom are themselves growers of maize [48]. In
Kenya, maize is important for both food security and
income generation for almost 90% of the rural popu-
lation [49], and drought-tolerant varieties are one response
to population growth, unreliable rainfall and climate
change – factors expected to increase drought risks to
maize growers in Africa in the future [48].
Discussion
The points we outline in the paper are not to be under-
stood as comprising an argument against mandatory label-
ling of GM foods or in support of GM crop development.
Instead, our aim is to highlight, in light of the concerns
raised by some stakeholders in our latest Social Audit of
the WEMA project, the important task facing African
governments of carefully weighing all the issues at stake in
the debate over labelling GM foods. In particular, govern-
ments need to find a way to resolve the perceived conflict
between their introduction of mandatory labelling laws –
which seemingly hinder GM crop production – and their
ambitious food security agendas that stress the need to in-
vest in agricultural biotechnology.
In North America, widespread use and consumption
of GM foods occurred before any debate about GM la-
belling even began. Consumers in African countries such
as Kenya, however, have a chance to take part in, and
shape, the debate on GM labelling as the introduction of
GM foods is a relatively new phenomenon in Africa.
That African governments seem inclined to take the pre-
cautionary approach to introducing GM foods and man-
dating labels is a rational move amidst the uncertainty
surrounding the public health impact of GM foods and
for safeguarding their agricultural exports to European
markets. However, agricultural stakeholders for the
most part interpret labelling regulations as implicit
opposition by some key decision-makers within gov-
ernment to GM food production [50], which contrib-
utes to misunderstandings, accusations and perceived
stigmatization. While the GOK’s introduction of GM
labelling regulations is commendable, it is equally import-
ant that the government consults various agricultural
stakeholders so that the latter know whether, and how,
they will be affected.
Many of the arguments put forth in favour of and against
mandatory GM labelling appear to be ad hominem.
The pro-labelling/anti-GMO group overemphasizes the‘right to know’ aspect of GM labelling, perhaps to avoid
supplying hard evidence that supports a ‘real need’ for la-
belling. The biotech industry, on the other hand, overem-
phasizes the cost aspect of GM labels, perhaps to avoid
the real fear of stigmatization and, in turn, consumer re-
jection of GM food products. We believe it is beneficial
for governments to consider the five points introduced in
this paper to obviate perceptions of discriminating against
or benefiting a particular group of stakeholders, which, we
hope, will contribute to minimizing the spread of misin-
formation concerning agricultural biotechnology.
Endnotes
aSocial auditing is a process whereby an audit team
collects, analyses and interprets descriptive, quantitative
and qualitative information from stakeholders to pro-
duce an account of a project's ethical, social, cultural and
commercialization performance and impact.
b‘Key agricultural stakeholders’ here refer to stake-
holders of the WEMA project whom we interviewed to
produce the annual Social Audit reports from 2009 to
2012. For each report, the viewpoints of 100 people from
across the five WEMA countries (Kenya, South Africa,
Mozambique, Tanzania and Uganda) were collected using
a quantitative questionnaire and a semi-structured inter-
view guide. The people interviewed fell under the following
stakeholder groups: technical resource and consultant;
academics and scientists; legal; agricultural extension
services; agricultural commercial enterprises; farmers’
associations; technology funders; science and technol-
ogy government departments; national agricultural research
systems; regional organizations working with small-scale
farmers; public/NGOs for public concerns; media; re-
gional national authorities; project regional personnel and
seed companies.
cTo learn more about the WEMA project, see [51].
dFull title of the gazette: Kenya Gazette Supplement
No 48 of 2012, Legal Notice No 40 (dated 25 May 2012).
Abbreviations
GM: genetically modified; GMO: genetically modified organism;
GOK: Government of Kenya; WEMA: Water Efficient Maize for Africa.
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